ADVERTISEMENT
Search

Pharmacy News

SARS-CoV-2’s spike protein seems to linger in body of long COVID patients

A study by researchers at Harvard has identified the presence of SARS-CoV-2’s spike protein in the blood of long COVID patients up to 1 year after infection, but not in people who fully recovered from the disease.

APhA creates tools to help pharmacists navigate reproductive health care for patients

In response to the Dobbs v. Jackson ruling, APhA has created numerous resources to help pharmacists navigate the nuances of how pharmacy practice has been affected.

Study finds lower prescription rates of SGLT-2 inhibitors and GLP-1 agonists associated with race and ethnicity

In a new study, researchers sought to examine differences in the prescribing of SGLT-2 inhibitors and glucagon-like peptide-1 (GLP-1) agonists among adults with type 2 diabetes along ethnic and racial groups. The American Diabetes Association recommends these as first-line treatments with or without metformin for people with type 2 diabetes who have or who are at high risk for atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease.

New study gives insight into statins and muscle pain

While many patients who stop taking statins say that adverse effects, including muscle pain, is to blame, a new study in The Lancet says the drugs are not the cause of the pain for most statin patients reporting it.

ACIP issues recommendations on seasonal influenza vaccines

According to CDC’s 2022–2023 Advisory Committee on Immunization Practices (ACIP) recommendations, all vaccines for the approaching influenza season will be quadrivalent. Trivalent influenza vaccines have been taken out of circulation.

RSS
123578910Last